title: Local postoperative morbidity following pre-operative irradiation in locally advanced breast cancer.
abstract: The authors have reviewed the medical files of 100 patients with locally advanced breast cancer (Stage III), who were treated in the Department of Surgery at the Institut Jules Bordet between 1974 and 1988. All patients received pre-operative radiotherapy (average total dose 45 Gy), which was associated with chemotherapy in 74% of patients. All patients were subsequently subjected to surgery, using a modified mastectomy in 92% of cases. Our data reveal an incidence of 25% local wound infection, 34% delayed wound healing, 63% seroma formation and 22% lymphoedema of the upper limb. It seems that local postoperative morbidity is increased in patients pre-operatively irradiated. This indicates that pre-operative chemotherapy may be preferable in these patients to minimize the local postoperative morbidity and its impact on the quality of life.
authors.affiliation: Department of Surgery, Institut Jules Bordet, Brussels, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Badr el Din
authors.forename: M
authors.initials: M
authors.lastname: Coibion
authors.forename: C
authors.initials: C
authors.lastname: Guenier
authors.forename: J M
authors.initials: JM
authors.lastname: Nogaret
authors.forename: I
authors.initials: I
authors.lastname: Lorent
authors.forename: P
authors.initials: P
authors.lastname: Van Houtte
authors.forename: E
authors.initials: E
authors.lastname: Tueni
authors.forename: W
authors.initials: W
authors.lastname: Mattheiem
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000628:therapy*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007902:Length of Stay; D015409:Mastectomy, Radical; D015413:Mastectomy, Simple; D008727:Methotrexate / Q000008:administration & dosage; D011379:Prognosis; D011788:Quality of Life; D011855:Radiodermatitis / Q000453:epidemiology*; D011878:Radiotherapy / Q000009:adverse effects*; D013203:Staphylococcal Infections / Q000453:epidemiology; D013530:Surgical Wound Infection / Q000453:epidemiology*; D014750:Vincristine / Q000008:administration & dosage; D014945:Wound Healing / Q000528:radiation effects*
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate